| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
A07AA Antibiotics
A07AA01 Neomycin
A07AA02 Nystatin
A07AA03 Natamycin
A07AA04 Streptomycin
A07AA05 Polymyxin B
A07AA06 Paromomycin
A07AA07 Amphotericin B
A07AA08 Kanamycin
A07AA09 Vancomycin
A07AA10 Colistin
A07AA11 Rifaximin
A07AA12 Fidaxomicin
A07AA51 Neomycin, combinations
A07AA54 Streptomycin, combinations
A07AB Sulfonamides
A07AB02 Phthalylsulfathiazole
A07AB03 Sulfaguanidine
A07AB04 Succinylsulfathiazole
A07AC Imidazole derivatives
A07AC01 Miconazole
A07AX Other intestinal anti-infectives
A07AX01 Broxyquinoline
A07AX02 Acetarsol
A07AX03 Nifuroxazide
A07AX04 Nifurzide
A07B Intestinal adsorbents
A07BA Charcoal preparations
A07BA01 Medicinal charcoal
A07BA51 Medicinal charcoal, combinations
A07BB Bismuth preparations
A07BC Other intestinal adsorbents
A07BC01 Pectin
A07BC02 Kaolin
A07BC03 Crospovidone
A07BC04 Attapulgite
A07BC05 Diosmectite
A07BC30 Combinations
A07BC54 Attapulgite, combinations
A07C Electrolytes with carbohydrates
A07CA Oral rehydration salt formulations
Subgroup A07CA is only included in the human ATC classification.
A07D Antipropulsives
A07DA Antipropulsives
A07DA01 Diphenoxylate
A07DA02 Opium
A07DA03 Loperamide
A07DA04 Difenoxin
A07DA05 Loperamide oxide
A07DA52 Morphine, combinations
A07DA53 Loperamide, combinations
A07E Intestinal anti-inflammatory agents
A07EA Corticosteroids acting locally
A07EA01 Prednisolone
A07EA02 Hydrocortisone
A07EA03 Prednisone
A07EA04 Betamethasone
A07EA05 Tixocortol
A07EA06 Budesonide
A07EA07 Beclometasone
A07EB Antiallergic agents, excluding corticosteroids
A07EB01 Cromoglicic acid
A07EC Aminosalicylic acid and similar agents
A07EC01 Sulfasalazine
A07EC02 Mesalazine
A07EC03 Olsalazine
A07EC04 Balsalazide
A07F Antidiarrheal micro-organisms
A07FA Antidiarrheal micro-organisms
A07FA01 Lactic acid producing organisms
A07FA02 Saccharomyces boulardii
A07FA51 Lactic acid producing organisms, combinations
A07X Other antidiarrheals
A07XA Other antidiarrheals
A07XA01 Albumin tannate
A07XA02 Ceratonia
A07XA03 Calcium compounds
A07XA04 Racecadotril
A07XA51 Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
|
|
להשלים
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
|
|
|
להשלים
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
|
|
|
להשלים
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
ֻCalcium
|
|
|
|
|
|
|
להשלים
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
|
|
להשלים
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
|
להשלים
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
|
להשלים
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
|
להשלים
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
|
להשלים
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
|
להשלים
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
להשלים
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
|
|
|
להשלים
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
|
|
להשלים
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
B06
|
|
|
|
Other hematological agents
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
|
להשלים
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
L04
|
|
|
|
Immunosuppressants
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
|
R07
|
|
|
|
Other respiratory system products
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
V20
|
|
|
|
Surgical dressings
|
כניסה 
עקבו אחרינו בפייסבוק